T 1439/09 (Sclerostin/UCB PHARMA) of 16.4.2013

European Case Law Identifier: ECLI:EP:BA:2013:T143909.20130416
Date of decision: 16 April 2013
Case number: T 1439/09
Application number: 99963986.7
IPC class: C07K 14/51
C07K 16/22
A61K 39/395
Language of proceedings: EN
Distribution: C
Download and more information:
Decision text in EN (PDF, 193.953K)
Documentation of the appeal procedure can be found in the Register
Bibliographic information is available in: EN
Versions: Unpublished
Title of application: Compositions and methods for increasing bone mineralization
Applicant name: UCB Pharma S.A.
Opponent name: ELI LILLY AND COMPANY
Board: 3.3.08
Headnote: -
Relevant legal provisions:
European Patent Convention Art 83
European Patent Convention Art 54
European Patent Convention Art 56
European Patent Convention Art 111(1)
Rules of procedure of the Boards of Appeal Art 13(3)
Keywords: Anonymous third party observations (deemed not to have been filed (see points 1.7, 1.8))
Sufficiency of disclosure (yes), novelty (yes), inventive step (yes)
Catchwords:

-

Cited decisions:
T 0367/96
T 0609/02
T 0146/07
Citing decisions:
-

11 references found.

Click X to load a reference inside the current page, click on the title to open in a new page.

EPC Articles

Offical Journal of the EPO

Case Law Book: III Amendments

General Case Law